JD HEALTH (06618.HK) -0.500 (-1.023%) Short selling $211.06M; Ratio 29.168% announced that the Board has authorized and approved a program to repurchase up to USD1 billion in value of the shares of the Company from the open market over a 48-month period starting from the approval date.The Board believed that the Proposed Share Repurchase in the present conditions will demonstrate the Company’s confidence in its current and long-term business outlook and prospects, and that the current financial resources of the Company would enable it to implement the Proposed Share Repurchase while maintaining a solid financial position.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)Related NewsJD HEALTH (06618.HK) 1Q26 Non-IFRS Net Profit Up 6% YoY to RMB1.874B
AASTOCKS Financial News